I have some ideas as to why Phanuel might want to keep a low profile, but these are just speculations right now.
I'm doing more research, and I'll post what I learn.
Trials in India are more than a little controversial at this time. There've been some abuses by foreign companies who violated the rights of their test subjects. It's a sore subject in the Indian legislature.
I mentioned Indian drug trials to a researcher I spoke with recently and she gave me the low down. Things are changing there. They have world class scientists. They're reforming the laws. But some people still look warily at companies that do trials there.
It would make sense work quietly and without publicity.
Market Data 
Markets 
AI
